Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono- and dual-antiplatelet therapy

BACKGROUND: Vorapaxar is indicated with standard antiplatelet therapy (APT) in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). OBJECTIVES: To evaluate the comparative effects of vorapaxar on platelet-fibrin clot characteristics (PFCC), coagulation, inflamm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Thromb Haemost
Hauptverfasser: Bliden, Kevin, Chaudhary, Rahul, Kuliopulos, Athan, Tran, Henry, Taheri, Hamid, Tehrani, Behnam, Rosenblatt, Arnold, Navarese, Eliano, Tantry, Udaya S., Gurbel, Paul A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6940524/
https://ncbi.nlm.nih.gov/pubmed/31444884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14616
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge